An open-label, single-arm, multi-institutional phase II trial of avelumab for recurrent, metastatic nasopharyngeal carcinoma.

被引：0
|
作者：
Sacco, Assuntina Gesualda
Messer, Karen
Leidner, Rom S.
Colevas, A. Dimitrios
Nieva, Jorge J.
Chau, Nicole Grace
Nangia, Chaitali Singh
Pinsky, Benjamin
Gold, Kathryn A.
Daniels, Gregory A.
Cohen, Ezra E. W.
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Earl A Chiles Res Inst, Portland, OR USA
[3] Stanford Canc Inst, Stanford, CA USA
[4] Univ Southern Calif, Los Angeles, CA USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Univ Calif Irvine, Ctr Comprehens Canc, Orange, CA 92668 USA
[7] Stanford Univ, Palo Alto, CA 94304 USA
[8] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA
[9] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS6092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS6092
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
    Ding, Xi
    Zhang, Wei-Jing
    You, Rui
    Zou, Xiong
    Wang, Zhi-Qiang
    Ouyang, Yan-Feng
    Peng, Lan
    Liu, You-Ping
    Duan, Chong-Yang
    Yang, Qi
    Lin, Chao
    Xie, Yu-Long
    Chen, Si-Yuan
    Liu, Yong-Long
    Gu, Chen-Mei
    Xie, Ruo-Qi
    Huang, Pei-Yu
    Hong, Ming-Huang
    Hua, Yi-Jun
    Chen, Ming-Yuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2571 - +
  • [2] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
    Hua, Yijun
    You, Rui
    Wang, Zhiqiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yanfeng
    Xie, Yulong
    Zou, Xiong
    Liu, Youping
    Duan, Chongyang
    Liu, Yonglong
    Gu, Chenmei
    Liu, Rongzeng
    Yang, Qi
    Jiang, Rou
    Zhang, Mengxia
    Ding, Xi
    Chen, Siyuan
    Lin, Chao
    Sun, Rui
    Chen, Mingyuan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [3] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: An open-label single-arm, phase II trial.
    Chen, Mingyuan
    Hua, Yijun
    You, Rui
    Wang, Zhi-Qiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yan-Feng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
    Kroiss, Matthias
    Quinkler, Marcus
    Johanssen, Sarah
    van Erp, Nielka P.
    Lankheet, Nienke
    Poellinger, Alexander
    Laubner, Katharina
    Strasburger, Christian J.
    Hahner, Stefanie
    Mueller, Hans-Helge
    Allolio, Bruno
    Fassnacht, Martin
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3495 - 3503
  • [5] A phase II, multicenter, open-label, single-arm trial of famitinib in patients with advanced recurrent and/or metastatic nasopharyngeal carcinoma (NPC) after two previous treatment regimens
    Huang, Yan
    Zhang, Li
    Pan, Jian-ji
    Hu, Guoqing
    Gang, Wu
    Xiong, Jian Ping
    Hu, Chaosu
    Lin, Lizhu
    Yu, Hao
    Jiang, Haoyuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Song, Zhengbo
    Lou, Guangyuan
    Wang, Yina
    Yang, Zhiping
    Wang, Wenxian
    Ji, Yongling
    Chen, Shiqing
    Xu, Chunwei
    Hu, Xiao
    Zhang, Yiping
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [7] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Zhengbo Song
    Guangyuan Lou
    Yina Wang
    Zhiping Yang
    Wenxian Wang
    Yongling Ji
    Shiqing Chen
    Chunwei Xu
    Xiao Hu
    Yiping Zhang
    [J]. BMC Medicine, 20
  • [8] TORIPALIMAB PLUS CHEMORADIOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL
    Xu, Xiaoting
    Huan, Jian
    Miao, Hui
    Wang, Hao
    Wang, Yue
    Zhu, Hongyu
    Jiang, Jun
    Zhou, Juying
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A384 - A384
  • [9] Camrelizumab plus apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma failing first-line therapy: An open-label, single-arm, phase II study
    Ding, X.
    Zhang, W.
    You, R.
    Zou, X.
    Wang, Z.
    Ouyang, Y-F.
    Liu, Y-L.
    Peng, L.
    You-Ping, L.
    Duan, C-Y.
    Yang, Q.
    Lin, C.
    Yulong, X.
    Chen, S-Y.
    Gu, C-M.
    Huang, P. Y.
    Hua, Y.
    Chen, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S846 - S846
  • [10] Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
    Cousin, Sophie
    Cantarel, Coralie
    Guegan, Jean-Philippe
    Mazard, Thibault
    Gomez-Roca, Carlos
    Metges, Jean-Philippe
    Bellera, Carine
    Adenis, Antoine
    Korakis, Iphigenie
    Poureau, Pierre-Guillaume
    Bourcier, Kevin
    Toulmonde, Maud
    Kind, Michele
    Rey, Christophe
    Auzanneau, Celine
    Bessede, Alban
    Soubeyran, Isabelle
    Italiano, Antoine
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 162 : 161 - 169
12345